170
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Factors Associated with Benzodiazepines Prolonged-Term Use in Post-Stroke Subjective Sleep Disturbance: A Single-Centre Retrospective Study from China

, , , &
Pages 2469-2481 | Published online: 09 Jun 2021

References

  • KatanM, LuftA. Global burden of stroke. Semin Neurol. 2018;38(2):208–211. doi:10.1055/s-0038-164950329791947
  • Wang Longde CJZZ. Report on stroke prevention and treatment in China (2019). Version 1 ed. Beijing: People’s Health Publishing House; 2020:189.
  • WangYJ, LiZX, GuHQ, et al. China stroke statistics 2019: a report from the national center for healthcare quality management in neurological diseases, China national clinical research center for neurological diseases, the Chinese stroke association, national center for chronic and non-communicable disease control and prevention, Chinese center for disease control and prevention and institute for global neuroscience and stroke collaborations. Stroke Vasc Neurol. 2020;5(3):211–239. doi:10.1136/svn-2020-00045732826385
  • LongdeW. Brief report on stroke prevention and treatment in China 2019. Chin J Cerebrovas Dis. 2020;17(5):272–281. doi:10.3969/j.issn.1672-5921.2020.05.008
  • SateiaMJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–1394. doi:10.1378/chest.14-097025367475
  • MimsKN, KirschD. Sleep and Stroke. Sleep Med Clin. 2016;11(1):39–51. doi:10.1016/j.jsmc.2015.10.00926972032
  • LeppavuoriA, PohjasvaaraT, VatajaR, KasteM, ErkinjunttiT. Insomnia in ischemic stroke patients. Cerebrovasc Dis. 2002;14(2):90–97. doi:10.1159/00006473712187012
  • CaoXL, WangSB, ZhongBL, et al. The prevalence of insomnia in the general population in China: a meta-analysis. PLoS One. 2017;12(2):e170772. doi:10.1371/journal.pone.0170772
  • RiemannD, BaglioniC, BassettiC, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700. doi:10.1111/jsr.1259428875581
  • KuoC. 5 - Cognitive behavioral therapy around the globe. In: SteinDJ, BassJK, HofmannSG, editors. Global Mental Health and Psychotherapy. Academic Press; 2019:87–126.
  • GudexC. Adverse effects of benzodiazepines. Soc Sci Med. 1991;33(5):587–596. doi:10.1016/0277-9536(91)90216-y1962230
  • VotawVR, GeyerR, RieselbachMM, McHughRK. The epidemiology of benzodiazepine misuse: a systematic review. Drug Alcohol Depend. 2019;200:95–114. doi:10.1016/j.drugalcdep.2019.02.03331121495
  • DaviesJ, RaeTC, MontaguL. Long-term benzodiazepine and Z-drugs use in England: a survey of general practice [corrected]. Br J Gen Pract. 2017;67(662):e609–13. doi:10.3399/bjgp17X69186528716996
  • AiragnesG, LemogneC, RenuyA, et al. Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort. BMC Public Health. 2019;19(1):566. doi:10.1186/s12889-019-6933-831088561
  • JanhsenK, RoserP, HoffmannK. The problems of long-term treatment with benzodiazepines and related substances. Dtsch Arztebl Int. 2015;112(1–2):1–7. doi:10.3238/arztebl.2015.000125613443
  • CasatiA, SedefovR, Pfeiffer-GerschelT. Misuse of medicines in the European Union: a systematic review of the literature. Eur Addict Res. 2012;18(5):228–245. doi:10.1159/00033702822572594
  • TakanoA, OnoS, YamanaH, et al. Factors associated with long-term prescription of benzodiazepine: a retrospective cohort study using a health insurance database in Japan. BMJ Open. 2019;9(7):e29641. doi:10.1136/bmjopen-2019-029641
  • MokharA, TillenburgN, DirmaierJ, KuhnS, HarterM, VertheinU. Potentially inappropriate use of benzodiazepines and z-drugs in the older population-analysis of associations between long-term use and patient-related factors. PEERJ. 2018;6:e4614. doi:10.7717/peerj.461429844949
  • KurkoTA, SaastamoinenLK, TahkapaaS, et al. Long-term use of benzodiazepines: definitions, prevalence and usage patterns - a systematic review of register-based studies. Eur Psychiatry. 2015;30(8):1037–1047. doi:10.1016/j.eurpsy.2015.09.00326545257
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders fifth editon (DSM-V). Arlington, VA: American Psychiatric Publishing; 2013:362–365.
  • JohnsonKG, JohnsonDC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med. 2010;6(2):131–137. doi:10.5664/jcsm.2776020411688
  • MasperoC, GianniniL, GalbiatiG, RossoG, FarronatoG. Obstructive sleep apnea syndrome: a literature review. Minerva Stomatol. 2015;64(2):97–109.25747430
  • BamfordJ, SandercockP, DennisM, BurnJ, WarlowC. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337(8756):1521–1526. doi:10.1016/0140-6736(91)93206-o1675378
  • MyersKA, MrkobradaM, SimelDL. Does this patient have obstructive sleep apnea? The rational clinical examination systematic review. JAMA. 2013;310(7):731–741. doi:10.1001/jama.2013.27618523989984
  • ForalP, KnezevichJ, DewanN, MaleskerM. Medication-induced sleep disturbances. Consult Pharm. 2011;26(6):414–425. doi:10.4140/TCP.n.2011.41421628140
  • NiX, ShergisJL, GuoX, et al. Updated clinical evidence of Chinese herbal medicine for insomnia: a systematic review and meta-analysis of randomized controlled trials. Sleep Med. 2015;16(12):1462–1481. doi:10.1016/j.sleep.2015.08.01226611943
  • TempleJL, BernardC, LipshultzSE, CzachorJD, WestphalJA, MestreMA. The safety of ingested caffeine: a comprehensive review. Front Psychiatry. 2017;8(80). doi:10.3389/fpsyt.2017.00080
  • EbrahimIO, ShapiroCM, WilliamsAJ, FenwickPB. Alcohol and sleep I: effects on normal sleep. Alcohol Clin Exp Res. 2013;37(4):539–549. doi:10.1111/acer.1200623347102
  • ChouinardS, PoulinJ, StipE, GodboutR. Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophr Bull. 2004;30(4):957–967. doi:10.1093/oxfordjournals.schbul.a00714515954201
  • TsunoN, BessetA, RitchieK. Sleep and depression. J Clin Psychiatry. 2005;66(10):1254–1269. doi:10.4088/jcp.v66n100816259539
  • CutlerAJ. The role of insomnia in depression and anxiety: its impact on functioning, treatment, and outcomes. J Clin Psychiatry. 2016;77(8):e1010. doi:10.4088/JCP.14076tx3c27561147
  • PangmanVC, SloanJ, GuseL. An examination of psychometric properties of the mini-mental state examination and the standardized mini-mental state examination: implications for clinical practice. APPL NURS RES. 2000;13(4):209–213. doi:10.1053/apnr.2000.923111078787
  • BaylanS, GriffithsS, GrantN, BroomfieldNM, EvansJJ, GardaniM. Incidence and prevalence of post-stroke insomnia: a systematic review and meta-analysis. Sleep Med Rev. 2020;49:101222. doi:10.1016/j.smrv.2019.10122231739180
  • Health NIOP. WHO collaborating centre for drug statistics methodology: ATC/DDD index. 2021.
  • ZungWW. A rating instrument for anxiety disorders. Psychosomatics. 1971;12(6):371–379. doi:10.1016/S0033-3182(71)71479-05172928
  • ZungWW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63–70. doi:10.1001/archpsyc.1965.0172031006500814221692
  • JohnsMW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–545. doi:10.1093/sleep/14.6.5401798888
  • SuhM, Choi-KwonS, KimJS. Sleep disturbances after cerebral infarction: role of depression and fatigue. J Stroke Cerebrovasc Dis. 2014;23(7):1949–1955. doi:10.1016/j.jstrokecerebrovasdis.2014.01.02924794949
  • ColinO, LabreucheJ, DeguilJ, et al. Preadmission use of benzodiazepines and stroke outcomes: the Biostroke prospective cohort study. BMJ Open. 2019;9(1):e22720. doi:10.1136/bmjopen-2018-022720
  • DelpontB, BlancC, OssebyGV, Hervieu-BègueM, GiroudM, BéjotY. Pain after stroke: a review. Rev Neurol-France. 2018;174(10):671–674. doi:10.1016/j.neurol.2017.11.011
  • KwahLK, DiongJ. National institutes of health stroke scale (NIHSS). J Physiother. 2014;60(1):61. doi:10.1016/j.jphys.2013.12.01224856948
  • RundeD. Calculated decisions: modified rankin scale (mRS) for neurologic disability. Emerg Med Pract. 2019;21(Suppl 6):D4–5.
  • MeschiaJF, BushnellC, Boden-AlbalaB, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. STROKE. 2014;45(12):3754–3832. doi:10.1161/STR.000000000000004625355838
  • ZhangP, LiYP, WuHJ, et al. Guidelines for the diagnosis and treatment of insomnia in Chinese adults (2017 Edition). Chin J Neurol. 2018;51(05):324–335. doi:10.3760/cma.j.issn.1006-7876.2018.05.002
  • HofmannSG, AsnaaniA, VonkIJ, SawyerAT, FangA. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognit Ther Res. 2012;36(5):427–440. doi:10.1007/s10608-012-9476-1
  • GlidewellRN, MoorcroftWH, Lee-ChiongT. Comorbid insomnia: reciprocal relationships and medication management. Sleep Med Clin. 2010;5(4):627–646. doi:10.1016/j.jsmc.2010.08.012
  • SchifanoF, ChiappiniS, CorkeryJM, GuirguisA. An insight into Z-drug abuse and dependence: an examination of reports to the European medicines agency database of suspected adverse drug reactions. Int J Neuropsychopharmacol. 2019;22(4):270–277. doi:10.1093/ijnp/pyz00730722037